409 related articles for article (PubMed ID: 21398608)
21. Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets.
Zharkova O; Salamah MF; Babak MV; Rajan E; Lim LHK; Andrade F; Gil CD; Oliani SM; Moraes LA; Vaiyapuri S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834844
[TBL] [Abstract][Full Text] [Related]
22. Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism.
Ramon S; Bancos S; Serhan CN; Phipps RP
Eur J Immunol; 2014 Feb; 44(2):357-69. PubMed ID: 24166736
[TBL] [Abstract][Full Text] [Related]
23. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4?
Forsman H; Önnheim K; Andreasson E; Dahlgren C
Scand J Immunol; 2011 Sep; 74(3):227-234. PubMed ID: 21535079
[TBL] [Abstract][Full Text] [Related]
24. Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization.
Yazid S; Leoni G; Getting SJ; Cooper D; Solito E; Perretti M; Flower RJ
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1718-24. PubMed ID: 20558817
[TBL] [Abstract][Full Text] [Related]
25. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature.
Pederzoli-Ribeil M; Maione F; Cooper D; Al-Kashi A; Dalli J; Perretti M; D'Acquisto F
Blood; 2010 Nov; 116(20):4288-96. PubMed ID: 20705760
[TBL] [Abstract][Full Text] [Related]
26. The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia.
Machado MG; Tavares LP; Souza GVS; Queiroz-Junior CM; Ascenção FR; Lopes ME; Garcia CC; Menezes GB; Perretti M; Russo RC; Teixeira MM; Sousa LP
FASEB J; 2020 Feb; 34(2):2749-2764. PubMed ID: 31908042
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the annexin A1-Fpr anti-inflammatory system in the ocular allergy.
Marmorato MP; Gimenes AD; Andrade FEC; Oliani SM; Gil CD
Eur J Pharmacol; 2019 Jan; 842():298-305. PubMed ID: 30419240
[TBL] [Abstract][Full Text] [Related]
29. Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
Vital SA; Becker F; Holloway PM; Russell J; Perretti M; Granger DN; Gavins FN
Circulation; 2016 May; 133(22):2169-79. PubMed ID: 27154726
[TBL] [Abstract][Full Text] [Related]
30. Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.
John CD; Sahni V; Mehet D; Morris JF; Christian HC; Perretti M; Flower RJ; Solito E; Buckingham JC
FASEB J; 2007 Apr; 21(4):1037-46. PubMed ID: 17218541
[TBL] [Abstract][Full Text] [Related]
31. Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.
Ansari J; Senchenkova EY; Vital SA; Al-Yafeai Z; Kaur G; Sparkenbaugh EM; Orr AW; Pawlinski R; Hebbel RP; Granger DN; Kubes P; Gavins FNE
Blood; 2021 Mar; 137(11):1538-1549. PubMed ID: 33512489
[TBL] [Abstract][Full Text] [Related]
32. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
33. Electroacupuncture decreases inflammatory pain through a pro-resolving mechanism involving the peripheral annexin A1-formyl peptide receptor 2/ALX-opioid receptor pathway.
Vieira C; Salm DC; Horewicz VV; Ludtke DD; Emer AA; Koerich JF; Mazzardo G; Elias S; Moré AOO; Mazzardo-Martins L; Cidral-Filho FJ; Reed WR; Piovezan AP; Martins DF
Pflugers Arch; 2021 Apr; 473(4):683-695. PubMed ID: 33474635
[TBL] [Abstract][Full Text] [Related]
34. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.
Cooray SN; Gobbetti T; Montero-Melendez T; McArthur S; Thompson D; Clark AJ; Flower RJ; Perretti M
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18232-7. PubMed ID: 24108355
[TBL] [Abstract][Full Text] [Related]
35. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
[TBL] [Abstract][Full Text] [Related]
36. Annexin 1 exerts anti-nociceptive effects after peripheral inflammatory pain through formyl-peptide-receptor-like 1 in rat dorsal root ganglion.
Pei L; Zhang J; Zhao F; Su T; Wei H; Tian J; Li M; Shi J
Br J Anaesth; 2011 Dec; 107(6):948-58. PubMed ID: 21990306
[TBL] [Abstract][Full Text] [Related]
37. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.
Chinthamani S; Odusanwo O; Mondal N; Nelson J; Neelamegham S; Baker OJ
Am J Physiol Cell Physiol; 2012 Apr; 302(7):C968-78. PubMed ID: 22205391
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of the formyl peptide receptor 2 gene.
Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
[TBL] [Abstract][Full Text] [Related]
39. Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells.
Tsai WH; Chien HY; Shih CH; Lai SL; Li IT; Hsu SC; Kou YR; Hsu HC
J Cell Physiol; 2012 Nov; 227(11):3661-9. PubMed ID: 22378018
[TBL] [Abstract][Full Text] [Related]
40. Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways.
Bozinovski S; Anthony D; Anderson GP; Irving LB; Levy BD; Vlahos R
Pharmacol Ther; 2013 Dec; 140(3):280-9. PubMed ID: 23880288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
